Biopsy-confirmed leukocytoclastic vasculitis following insurance-mandated switch from dupilumab to lebrikizumab in a patient with severe atopic dermatitis

JAAD Case Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles